Selected article for: "death rate and different group"
Author: Guang Yang; Zihu Tan; Ling Zhou; Min Yang; Lang Peng; Jinjin Liu; Jingling Cai; Ru Yang; Junyan Han; Yafei Huang; Shaobin He
Title: Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
  • Document date: 2020_4_4
    • ID: mwttkclk_28
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 31.20038935 doi: medRxiv preprint suggested by several groups. 12, 32 However, the clinical evidence is still missing. In this report, we found that in the 43 COVID-19 patients with hypertension treated with ARBs/ACEIs before and after diagnosed with SARS-CoV-2 infection, the concentrations of inflammatory CRP and procalcitonin were signific.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 31.20038935 doi: medRxiv preprint suggested by several groups. 12, 32 However, the clinical evidence is still missing. In this report, we found that in the 43 COVID-19 patients with hypertension treated with ARBs/ACEIs before and after diagnosed with SARS-CoV-2 infection, the concentrations of inflammatory CRP and procalcitonin were significantly lower compared with those treated with non-ARBs/ACEIs. ARBs/ACEIs treatment also resulted in a lower death rate and less critical cases in these patients. We did not find the concentrations of IL-6 in the ARBs/ACEIs group to be significantly different from that in the non-ARBs/ACEIs controls, which suggests that ARBs/ACEIs treatment alone might not be efficient in modulating the production of this cytokine. However, combining of ARBs/ACEIs and IL-6R blockade could presumably have a synergic effect in regulating the elevated inflammatory response in COVID-19 patients with preexisting hypertension, which could be tested in future clinical trials.

    Search related documents:
    Co phrase search for related documents
    • arb acei and clinical evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • arb acei and clinical trial: 1, 2, 3, 4, 5, 6
    • arb acei and inflammatory crp: 1, 2
    • arb acei and inflammatory response: 1, 2, 3, 4, 5
    • arb acei group and inflammatory crp: 1
    • arb acei group and inflammatory response: 1
    • arb acei treatment and blockade arb acei: 1
    • arb acei treatment and clinical evidence: 1, 2
    • arb acei treatment and clinical trial: 1, 2
    • arb acei treatment and inflammatory response: 1, 2
    • clinical evidence and cytokine production: 1, 2, 3, 4, 5, 6, 7
    • clinical evidence and cytokine production modulate: 1
    • clinical evidence and death rate: 1, 2, 3, 4, 5, 6, 7
    • clinical evidence and future clinical trial: 1, 2, 3, 4
    • clinical evidence and group suggest: 1
    • clinical evidence and hypertension patient: 1, 2
    • clinical evidence and inflammatory crp: 1, 2, 3
    • clinical evidence and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical evidence and low death rate: 1